Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S268400
Reexamination Certificate
active
07872031
ABSTRACT:
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.
REFERENCES:
patent: 2005/040154 (2005-05-01), None
patent: 2005/040345 (2005-05-01), None
Lindsey et al. Rational Synthesis of B-Substituted Chlorin Building Blocks, 2000, Journal of Organic Chemistry,65,7919-7929.
Eder et al. Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer. 2009, Clinical Cancer Research, 15, 2207-2214.
Sattler et al. c-Met and Hepatocyte Growth Factor: Potential as Novel Targets in Cancer Therapy. 2007, Current Oncology Reports, 9, 102-108.
Aronov Alexander
Bethiel Randy Scott
Davies Robert J.
Deininger David D.
Farmer Luc
McDowell Brian
Pearson Daniel A.
Vertex Pharmaceuticals Incorporated
Wilson James O
LandOfFree
c-MET protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with c-MET protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and c-MET protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2667601